Alpha Teknova (TKNO) Revenue & Revenue Breakdown
Alpha Teknova Revenue Highlights
Latest Revenue (Y)
$37.74M
Latest Revenue (Q)
$9.79M
Main Segment (Y)
Lab Essentials
Main Geography (Y)
UNITED STATES
Alpha Teknova Revenue by Period
Alpha Teknova Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $37.74M | 2.89% |
| 2023-12-31 | $36.68M | -11.43% |
| 2022-12-31 | $41.42M | 12.27% |
| 2021-12-31 | $36.89M | 17.88% |
| 2020-12-31 | $31.30M | 55.75% |
| 2019-12-31 | $20.09M | - |
Alpha Teknova generated $37.74M in revenue during NA 2024, up 2.89% compared to the previous quarter, and up 187.84% compared to the same period a year ago.
Alpha Teknova Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | $9.79M | 5.72% |
| 2024-12-31 | $9.27M | -3.25% |
| 2024-09-30 | $9.58M | -0.40% |
| 2024-06-30 | $9.61M | 3.49% |
| 2024-03-31 | $9.29M | 18.09% |
| 2023-12-31 | $7.87M | -3.70% |
| 2023-09-30 | $8.17M | -29.13% |
| 2023-06-30 | $11.53M | 26.38% |
| 2023-03-31 | $9.12M | 15.59% |
| 2022-12-31 | $7.89M | -26.20% |
| 2022-09-30 | $10.69M | -8.54% |
| 2022-06-30 | $11.69M | 4.87% |
| 2022-03-31 | $11.15M | 10.26% |
| 2021-12-31 | $10.11M | 7.64% |
| 2021-09-30 | $9.39M | 12.98% |
| 2021-06-30 | $8.31M | -8.43% |
| 2021-03-31 | $9.08M | -10.62% |
| 2020-12-31 | $10.16M | 13.06% |
| 2020-09-30 | $8.98M | 48.64% |
| 2020-06-30 | $6.04M | -1.11% |
| 2020-03-31 | $6.11M | - |
Alpha Teknova generated $9.79M in revenue during Q1 2025, up 5.72% compared to the previous quarter, and up 124.51% compared to the same period a year ago.
Alpha Teknova Revenue Breakdown
Alpha Teknova Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|
| Other Product | $1.76M | $1.15M | $1.20M | $1.39M |
| Clinical Solutions | $7.10M | $6.74M | $8.45M | $6.79M |
| Lab Essentials | $28.88M | $28.80M | $31.77M | $27.18M |
| Sample Transport | - | - | $6.00K | $1.53M |
Alpha Teknova's latest annual revenue breakdown by segment (product or service), as of Dec 24: Lab Essentials (76.52%), Clinical Solutions (18.80%), and Other Product (4.68%).
Quarterly Revenue by Product
| Product/Service | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lab Essentials | $7.79M | $8.12M | $6.82M | $7.16M | $7.64M | $7.27M | $6.69M | $7.27M | $7.58M | $7.26M | $6.93M | $9.47M | $8.39M | $6.97M | $6.74M | $7.20M | $6.46M |
| Clinical Solutions | $2.06M | $1.16M | $1.85M | $1.96M | $1.56M | $1.72M | $879.00K | $597.00K | $3.65M | $1.61M | $772.00K | $919.00K | $2.94M | $3.81M | $2.44M | $1.69M | $1.59M |
| Other Product | $435.00K | $516.00K | $597.00K | $451.00K | $411.00K | $306.00K | $300.00K | $298.00K | $293.00K | $255.00K | $185.00K | $303.00K | $354.00K | $354.00K | $432.00K | $434.00K | $227.00K |
| Sample Transport | - | - | - | - | - | - | - | - | - | - | - | - | $6.00K | $495.00K | $73.00K | $37.00K | - |
Alpha Teknova's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Lab Essentials (75.75%), Clinical Solutions (20.03%), and Other Product (4.23%).
Alpha Teknova Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|
| Non-US | $1.83M | $1.68M | $1.32M | - |
| UNITED STATES | $35.92M | $35.00M | $40.10M | - |
| Non Us | - | - | - | $1.08M |
| U S | - | - | - | $35.81M |
Alpha Teknova's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (95.16%), and Non-US (4.84%).
Quarterly Revenue by Country
| Country | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UNITED STATES | $9.78M | $9.27M | $8.76M | $9.06M | $9.23M | $8.87M | $7.37M | $7.83M | $11.07M | $8.73M | $7.61M | $10.38M | $11.29M | $10.82M | $9.11M | $8.06M | - |
| Non-US | $510.00K | $523.00K | $501.00K | $519.00K | $386.00K | $420.00K | $495.00K | $342.00K | $452.00K | $395.00K | $277.00K | $308.00K | $405.00K | $327.00K | $278.00K | - | - |
| Non Us | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $192.00K | $252.00K | - |
| U S | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $9.92M | - | - |
Alpha Teknova's latest quarterly revenue breakdown by geography, as of Jun 25: UNITED STATES (95.04%), and Non-US (4.96%).
Alpha Teknova Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| IRWD | Ironwood Pharmaceuticals | $351.41M | $85.24M |
| CGC | Canopy Growth | $297.15M | $64.66M |
| ACB | Aurora Cannabis | $233.29M | $64.42M |
| CERS | Cerus | $180.27M | $52.45M |
| LFCR | Lifecore Biomedical | $128.26M | $35.15M |
| SOPH | SOPHiA GENETICS | $62.37M | $15.78M |
| XGN | Exagen | $55.64M | $17.20M |
| SLN | Silence Therapeutics | $43.26M | $142.00K |
| TKNO | Alpha Teknova | $37.74M | $9.79M |
| ACIU | AC Immune | $14.80M | - |